Richard Pizzi is editor of The Hospitalist. He has been an editor at Frontline Medical Communications since 2015, and previously served as editor of MDedge publications Hospitalist News and ID Practitioner. He has also worked as an editor and in editorial management roles for HIMSS Media, MedTech Media, and the American Association for Clinical Chemistry. Follow him on Twitter @richpizzi
News
New HIV antiretroviral guidelines embrace PrEP, early ART
The International Antiviral Society–USA has updated its recommendations for the use of antiretroviral drugs to treat or to prevent HIV infection...
News
U.S. to jump-start antibiotic resistance research
The CDC is providing $67 million to help U.S. health departments address antibiotic resistance and related patient-safety concerns.
News
Hepatitis outlook: July 2016
A recent study found a strong relationship between Helicobacter pylori infection and chronic hepatitis B. Read about this and other notable...
News
HIV research update: Early July 2016
Short cycle antiretroviral therapy is a viable option for adherent HIV-infected young people who are stable on efavirenz-based ART. Read about...
News
Global HIV/AIDS mortality declines, but infection rate is unimproved
HIV/AIDS mortality has been declining at a steady pace since 2005, but the annual rate of new infections has remained relatively constant in that...
News
Ebola research update: June 2016
Sexual transmission of the Ebola virus can have large effects on epidemic dynamics, according to a recent study. Read about this and other notable...
News
HIV research update: Late June 2016
An Australian study found that HIV-infected people less likely to be using antiretroviral therapy were younger and had a more recent diagnosis of...
News
Hepatitis Outlook: June 2016
Negative media reports about the safety of the hepatitis B vaccine in China harmed perception of the vaccine’s safety among patients, according to...
News
HBV/HIV coinfection a significant risk factor for inpatient mortality
Patients coinfected with HBV and HIV are at greater risk for in-hospital mortality, particularly in liver-related admissions, compared with HBV...
News
HIV research update: Early June 2016
Heavy drinking may increase a key inflammatory marker in HIV-infected individuals with suppressed infection. Read about this and other notable...
News
Recurrent C. diff infection much more costly to treat
The costs of treating patients with recurrent C. difficile infection are approximately two to three times the treatment costs for patients with...
News
FDA approves first cholera vaccine for travelers
The FDA has approved a vaccine for the prevention of cholera caused by serogroup O1 in adults aged 18-64 years traveling to cholera-affected areas...